Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.1.4 (
glutamate dehydrogenase
)
4,358
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Evidence for the localization of up to 25-30% of the total
glutamate dehydrogenase
activity in rabbit liver cell hyaloplasm has been obtained. Differences were revealed in the properties of
glutamate dehydrogenase
from the hyaloplasm and mitochondria. The ratios of activities in the amination/deamination reactions as measured at optimal values of pH for the mitochondrial and liver enzymes were 3.7 and 1.0, respectively. The enzyme preparations isolated from the both fractions appeared to be electrophoretically homogeneous and had a subunit molecular mass of about 56 +/- 2 kDa. Fresh preparations of mitochondrial and hyaloplasm liver
glutamate dehydrogenase
contained several oligomeric forms, predominantly with M of 350 and 280 kDa, respectively. Data from gel-filtration on Sephacryl S-300 are suggestive of a complex (M = 800 kDa) formation between liver hyaloplasm
glutamate dehydrogenase
(280 kDa) and NAD-kinase (
440 kDa
); this reaction is accompanied by simultaneous activation of these enzymes (3.5- and 2.4-fold, respectively).
...
PMID:[Study of complex formation between NAD-kinase and glutamate dehydrogenase, isolated from rabbit liver hyaloplasm]. 821 69